Monitoring treatment response using an ultra-sensitive ctDNA assay in advanced esophagogastric cancer patients
{{output}}
To explore whether ultra-sensitive circulating tumor DNA (ctDNA) profiling enables earlier prediction of treatment response and detection of disease progression, we applied NeXT Personal, an ultra-sensitive bespoke tumor-informed liquid biopsy platform, to pro... ...
